CAM
ARTV

Cormorant Asset Management’s Artiva Biotherapeutics, Inc. Common Stock ARTV Stock Holding History

Cormorant Asset Management’s Portfolio ARTV Stock Details ARTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-103,633
Closed -$1.04M – 51
2024
Q4 		$1.04M Hold
103,633
– – 0.06% 47
2024
Q3 		$1.6M Buy
+103,633
New +$1.6M 0.08% 44